ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Sanofi-Aventis ADS
(NY:
SNY
)
54.50
USD
+0.29 (+0.53%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Blog posts about Sanofi-Aventis ADS
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
(BMY) Bristol-Myers Squibb Company Earns Good News From FDA
Today 12:00 EDT
Bristol-Myers Squibb Company (BMY) recently received positive news from the US Food and Drug... Visit StockBlogHub to view complete post.
Read More
category
CELG
,
Sanofi/Aventis
,
Celgene Corporation
, and 5 more.
from
Stock Blog Hub
(SNY) Sanofi Earnings Plummet – Outlook Maintained
May 16, 2013
Sanofi (SNY) reported first quarter 2013 business earnings of 81 cents per American Depository... Visit StockBlogHub to view complete post.
Read More
category
ADS
,
JNJ
,
Sanofi/Aventis
, and 5 more.
from
Stock Blog Hub
Reference Points for Sanofi-Aventis
May 16, 2013
New York, May 16th (TradersHuddle.com) - Sanofi-Aventis ( NYSE:SNY ) closed the trading day at $54.48, near its 50 day moving average that is set at $52.03. Sanofi-Aventis' price action is just above...
Read More
from
TradersHuddle.com
Sanofi Smear Campaign to Limit Plavix Competition
May 14, 2013
category
SNY
from
YCharts
Approaching Resistance: Sanofi-Aventis
May 14, 2013
New York, May 14th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) are trading very close to calculated resistance at $55.77. The stock ended the trading session at just $54.83, which is...
Read More
from
TradersHuddle.com
Sanofi-Aventis Is Close to Resistance
May 08, 2013
New York, May 8th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) are trading very close to calculated resistance at $55.77. The stock ended the trading session at just $53.63, which is...
Read More
from
TradersHuddle.com
Sanofi-Aventis Is Close to the 50 Day Moving Average
May 07, 2013
New York, May 7th (TradersHuddle.com) - Sanofi-Aventis ( NYSE:SNY ) closed the trading day at $53.04, near its 50 day moving average that is set at $51.00. Sanofi-Aventis' price action is just above...
Read More
from
TradersHuddle.com
Is Sanofi-Aventis Breaking Out?
May 03, 2013
New York, May 3rd (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) closed the session at $55.00 just above calculated resistance at $54.98. The stock moved to what appears to be a higher...
Read More
from
TradersHuddle.com
$50,000-a-Year MS Drugs: Pharma Growth Battle
May 01, 2013
category
NVS
,
SNY
,
BIIB
from
YCharts
Sanofi-Aventis Is Near Resistance
April 30, 2013
New York, April 30th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) are trading very close to calculated resistance at $54.98. The stock ended the trading session at just $54.50, which is...
Read More
from
TradersHuddle.com
Biogen Stock Up on New MS Drug Sales
April 29, 2013
category
NVS
,
SNY
,
BIIB
from
YCharts
Stocks to Watch: Micron Technology, Inc.(NASDAQ:MU), Sanofi SA (ADR)(NYSE:SNY), Ford Motor Company (NYSE:F)
April 26, 2013
Austin, TX -- (SBWIRE) -- 04/26/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues...
Read More
from
SBWire - Latest Press Releases
Stocks Recap: Banco Santander, Dana Holding Corporation, Halcon Resources Corp, Sanofi SA
April 26, 2013
Dallas, TX -- (SBWIRE) -- 04/26/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
Trading Idea: What to Expect as Sanofi-Aventis Breaks Resistance
April 25, 2013
New York, April 25th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) closed the session at $54.74 just above calculated resistance at $54.48. The stock effectively broke out and grasped the...
Read More
from
TradersHuddle.com
Investors Buzz: Sanofi, Phillips, Dynavax, Albany Molecular
April 24, 2013
Dallas, TX -- (SBWIRE) -- 04/24/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
Sanofi-Aventis Is Close to Resistance
April 23, 2013
New York, April 23rd (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) are trading very close to calculated resistance at $54.48. The stock ended the trading session at just $52.96, which is...
Read More
from
TradersHuddle.com
(REGN) Regeneron Pharmaceuticals Rated Neutral Again
April 18, 2013
We recently maintained our Neutral recommendation on biopharmaceutical company, Regeneron... Visit StockBlogHub to view complete post.
Read More
category
Regeneron Pharmaceuticals Inc
,
REGN
,
Biotechnology
, and 7 more.
from
Stock Blog Hub
(GSK) GlaxoSmithKline’s Flu Vaccine Approved
April 18, 2013
GlaxoSmithKline(GSK) recently announced the receipt of marketing authorization for its four-strain... Visit StockBlogHub to view complete post.
Read More
category
Glaxosmithkline plc
,
Sanofi/Aventis
,
Charles River Laboratories International Inc
, and 7 more.
from
Stock Blog Hub
Notable Gainers: Sanofi SA, Telefonica Brasil SA, Grupo Televisa SAB, HomeAway
April 18, 2013
Lakeway, NY -- (SBWIRE) -- 04/18/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on...
Read More
from
SBWire - Latest Press Releases
Sanofi-Aventis Is Close to Resistance
April 18, 2013
New York, April 18th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) are trading very close to calculated resistance at $54.48. The stock ended the trading session at just $52.44, which is...
Read More
from
TradersHuddle.com
Sanofi-Aventis Broke Resistance
April 17, 2013
New York, April 17th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) closed the session at $54.37 just above calculated resistance at $52.99. The stock moved to what appears to be a higher...
Read More
from
TradersHuddle.com
Stocks in Focus: Rambus, Sanofi, Myriad Genetics, Netflix
April 16, 2013
Lakeway, NY -- (SBWIRE) -- 04/16/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on...
Read More
from
SBWire - Latest Press Releases
Trading Idea: What to Expect as Sanofi-Aventis Breaks Resistance
April 12, 2013
New York, April 12th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) closed the session at $52.62 just above calculated resistance at $52.09. The stock effectively broke out and grasped the...
Read More
from
TradersHuddle.com
(SNY) Sanofi/Transgene Inks Immunotherapy Deal
April 11, 2013
Sanofi (SNY) recently entered into a collaboration Transgene for the production of immunotherapy... Visit StockBlogHub to view complete post.
Read More
category
Sanofi/Aventis
,
ABT
,
Rydex Inverse 2x S&P MidCap 400
, and 13 more.
from
Stock Blog Hub
Sanofi-Aventis Is Near Resistance
April 10, 2013
New York, April 10th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) are trading very close to calculated resistance at $52.09. The stock ended the trading session at just $51.55, which is...
Read More
from
TradersHuddle.com
(MRK) Pharma & Biotech Stock Outlook – Apr 2013 – Zacks Analyst Interviews
April 07, 2013
The pharmaceutical industry has been showing signs of recovery from one of the biggest patent... Visit StockBlogHub to view complete post.
Read More
category
Mylan Inc/
,
Glaxosmithkline plc
,
TEVA
, and 47 more.
from
Stock Blog Hub
Did You Miss the Post-Crisis Doubling of U.S. Stocks? Well, There’s Europe
April 05, 2013
category
TOT
,
SI
,
BP
, and 9 more.
from
YCharts
Is Sanofi-Aventis Closing in to Resistance?
April 05, 2013
New York, April 5th (TradersHuddle.com) - Shares of Sanofi-Aventis ( NYSE:SNY ) are trading very close to calculated resistance at $52.09. The stock ended the trading session at just $51.32, which is...
Read More
from
TradersHuddle.com
(NVS) Novartis Drug Candidate Earns Good News
April 04, 2013
Novartis (NVS) recently announced that the US Food and Drug Administration (FDA) rendered... Visit StockBlogHub to view complete post.
Read More
category
Sanofi/Aventis
,
EC
,
Charles River Laboratories International Inc
, and 11 more.
from
Stock Blog Hub
Stocks in Spotlight: Allergan, Sanofi SA, Lifelock Inc, the Home Depot
April 03, 2013
Dallas, TX -- (SBWIRE) -- 04/03/2013 -- Marketbuzzreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the...
Read More
from
SBWire - Latest Press Releases
< Previous
1
2
3
4
5
6
7
8
9
...
35
36
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
2
The Top 5 Spookiest Technologies
Nick Shchetko
3
The Tesla Model S Is the New Toyota Prius
Michael Comeau
4
Individual Investors and the Terrible, Horrible, No Good, Very Bad Day
Joe Digiammo
5
Black Swan Watch: Mexico's Super Volcano Could Be the Next Market Catalyst
Duncan Parker
See All Articles
»
Financial Product Guide